IAPs as therapeutic targets in haematological malignancies

Author： Langemeijer SMC de Graaf AO Jansen JH

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.8, 2008-08, pp. : 981-993

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apoptosis regulating proteins as targets of therapy for haematological malignancies

By Kornblau S.M. Konopleva M. Andreeff M.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2027-2057

Informa Healthcare

Access to resources Recommend Favorite

Targeting the proteasome as a therapeutic strategy against haematological malignancies

By Orlowski Robert Z Zeger Erik L

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 117-130

Informa Healthcare

Access to resources Recommend Favorite

Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?

Current Medicinal Chemistry, Vol. 23, Iss. 22, 2016-07 ,pp. : 2350-2362

Bentham Science Publishers

Access to resources Recommend Favorite

The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2100-2110

Bentham Science Publishers

Access to resources Recommend Favorite

RNAi Screening for Therapeutic Targets in Human Malignancies

Current Pharmaceutical Biotechnology, Vol. 8, Iss. 6, 2007-12 ,pp. : 337-343

Bentham Science Publishers

Access to resources Recommend Favorite